Jerry Del Colliano’s Post

NEW: Hipgnosis Songs' failed continuation vote may leave its investment manager in a “do or die” position, with the board's termination of the investment advisory agreement seen as the most likely outcome. There are also questions about whether Blackstone, which would be the ultimate provider of capital in a take-private offer by the investment manager, would want to buy the portfolio or cut its loses and move on. Full story:

Shareholder rebuke of Cumulus • Cumulus has upped their offer and delivered the needed support to do a debt exchange that buys them more time, but there is a big downside. • Shareholders are in ill humor as they recently rebuked the company, its CEO and c-suite executives – here’s what Cumulus had to admit to the government. • Cumulus gets a few more years, debt holders get a higher payout but it’s their next move that matters most. • The best outcome that can be expected from this lopsided debt exchange. • How both equity and debt investors are likely to get screwed by Cumulus. https://lnkd.in/eAyU9Zfj

Blackstone urges Hipgnosis shareholders to 'take no action' as it weighs response to Concord bid. Blackstone has advised Hipgnosis Songs (SONG) shareholders to “take no action” in response to Concord Music’s increased offer to take over the trust, as the private equity giant considers its options. Shavar de Vries Halberstadt. Check out Valeria Martinez’'s latest article 👇 https://incm.pub/3Wehigu #investing #assetmanagement #wealthmanagement #finance

It is always a good time to add some diversity to your portfolio! From music royalties and healthcare investments to storage facilities and more, our diverse offerings are designed to offer stability and growth potential in these volatile times. We invite you to join our upcoming webinar on Wednesday, July 3rd, where we’ll delve into these unique investment opportunities and how they can strengthen your financial future. Webinar Link here =>  https://lnkd.in/gu_rvYVb For Eligible Investors Only #invest #investing #alternativeinvestments #accreditedinvestors #investingnews #investors

You may have heard that BMAT runs on 3 CEOs now, following the infallible business principle 'the more the merrier'. Well, it is true, but also part of the plan. Read all about it here: https://lnkd.in/dgsFDbid.

Picture this - an orchestra playing a symphony, each instrument echoing in perfect harmony. Now visualize a successful M&A deal, where due diligence is the maestro conducting the symphony. Navigating a maze of contracts, financial statements, and legal documents might seem unimpressive. Yet, it's the heart of M&A - due diligence. It's laborious but undeniably critical. Have you ever splurged on an item only to uncover its flaws later? Ouch, right? Multiply that sting by a hundred. That's an M&A deal gone sour without sufficient due diligence. It's the 'pre-flight check' of every M&A voyage, revealing hidden issues and risks before you invest a dime. But what does it entail? It's a dive into financial history, an intricate examination of contracts, and an extensive evaluation of liabilities. Imagine lifting the carpet and scanning for dust. That's due diligence - unmasking potential dangers and assessing a deal's genuine value. In essence, it's like gazing into a crystal ball in an unpredictable M&A world. It paves the path with vital information, empowering decision-makers to steer their venture wisely. So, before you take the plunge, scrutinize every detail, leave no stone unturned. That's the role of due diligence - the unsung hero of M&A. Eager to hear your thoughts on due diligence in M&A. Join the conversation and share your insights! #investmentbanking #mergersandacquisitions #finance

New Post: Hipgnosis Delays Half-Year Financial Results Over Valuation Concerns - https://lnkd.in/gcbNT6wn - Hipgnosis Songs Fund has announced a last-second delay in publishing interim results for the six months ended Sept. 30, citing concerns over its valuation following a series of hiccups for the Merck Mercuriadis-led company. The fund, which owns full or partial rights to the song catalogs of artists ranging from Justin Bieber, Neil Young, Bruno Mars, Jimmy Iovine, 50 Cent, Shakira, Blondie, Justin Timberlake, Lindsey Buckingham and many more, was scheduled to publish it financial results on Tuesday (Dec. 19) but now expects to announce on New Year’s Eve, according to a regulatory filing. In explaining the delay, the Hipgnosis board said the valuation it received from an independent firm was “materially higher than the valuation implied by proposed and recent transactions in the sector,” namely two deals involving itself: a proposed $417.5 million sale of 29 catalogs to Blackstone-backed Hipgnosis Songs Capital, a price reflecting a 24.3% discount from a valuation dated March 31, and last week’s sale of 20,000 “non-core songs” to an undisclosed buyer for $23.1 million, which it said reflects a 14.2% discount on the songs’ valuation as of early fall. Related What Happens to Hipgnosis Songs Fund Now? 12/19/2023 Due to the disparity between the independent valuation and the “implied” one tied to recent trends and proposed sales, the board sought advice from its in-house investment advisor, Hipgnosis Song Management Limited, which delivered a “heavily caveated” opinion that led to the board’s concerns as to the valuation of HSF listed in the interim results scheduled to be disclosed today. Hipgnosis is comprised of three companies: Hipgnosis Song Management, Hipgnosis Songs Capital and Hipgnosis Songs Fund. The latter of the three has been mired in controversy in recent months after it was announced that the London-listed trust would not pay its investors a dividend because of new, lower projections for revenue. On Oct. 26, investors of the fund overwhelmingly demanded structural changes to the music rights company, with more than 80% of Hipgnosis investors voting in favor of the board drawing up “proposals for the reconstruction, reorganization or winding-up of the company to shareholders for their approval within six months.” Related Hipgnosis Appoints Daniel Pounder as CFO, Jonathan Baker as General Counsel 12/19/2023 Last month the company a

📰#MUBUTVNews Dividend shocker shows need for some robust governance at Hipgnosis Shareholders now almost certain to reject stinker of a deal to sell fifth of music rights catalogue to Blackstone It was a good idea: capitalise on the booming interest in “alternative” asset classes and launch a quoted fund to buy music rights. The bulk of the royalty income would flow to shareholders as dividends. Every addition of a new back catalogue would bring diversity to the portfolio. Thus Hipgnosis Songs Fund debuted on the London stock market at 100p a share in 2018, with the music industry veteran Merck Mercuriadis setting the beat as the deal-doing investment adviser. For a while, progress was harmonious. Shareholders were tapped regularly to fund purchases of the back catalogues of the likes of Blondie, Red Hot Chili Peppers and Neil Young. The share price peaked at 129p in late 2021. Since then, though, it’s been downhill fast, to the point where the gap between the fund’s view of the worth of the assets – or, rather, the external valuer’s view – and the share price is huge. The official value is 150p-ish compared with 65p in the market. Continue reading... https://vist.ly/dtxz

What a Soros owned Audacy means • Is influence or investment driving the Soros purchase of Audacy? • Where Cumulus stands in all of this – yes, Cumulus. • It isn’t just bankrupt companies Soros is after: The prime radio group they are eyeing as part of a three-group rollup. • What has conservatives worried about the Soros deal beyond political clout. • A person and a company to watch under the radar in this rollup. https://lnkd.in/e6dufQMd

Hipgnosis Songs spikes on acquisition news… Concord Chorus, a firm controlled by Alchemy Copyrights, is acquiring Hipgnosis Songs Fund (SONG) for $1.4 billion. SONG investors will receive $1.16 per share, a 32% premium over the previous day's closing price. Apollo will finance the acquisition, taking a minority stake in the bidding vehicle. Check out Hipgnosis Songs Fund 👉 https://lnkd.in/eiqmGQNa SONG's board unanimously recommends the deal, seeing it as an opportunity for shareholders to realise their holdings. Shareholders rejected a continuation vote last September, prompting the board to explore options to maximize value. The deal includes a contingent consideration clause and has garnered support from major shareholders. Peel Hunt analyst Anthony Leatham views the development positively, seeing potential to realise significant value from SONG's portfolio and close the share price discount. However, there may still be hurdles to overcome for the deal to progress fully. #investing #business #economy #markets #money #businessintelligence Full article: https://lnkd.in/ejtpZxKd